Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
An overview of CEPA requirements for organizations operating in Canada. Learn key obligations, compliance responsibilities, and best practices across all sectors.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Learn about the upcoming changes in medical device regulations. By May 2021, all devices must comply with the new EU Regulation. Find out the deadlines for re-certification and how this impacts medical devices on the market.
Explore recent regulatory changes in the EU, including microplastic restrictions, microbial safety guidelines for packaging, and updates to IFRA standards. Discover international shifts in cosmetic regulations in Russia, Saudi Arabia, and China, and insights from the Chartres Congress.
New REACH provisions require registrants to update dossiers by 1st January 2020. Changes include nanoform characterisation and safety assessment. Industry finds deadline too tight. Learn more about registering nanoforms and REACH annex changes.
Upstream authorisation dossiers for hexavalent chromium compounds lack specificity and transparency, leading to incomplete risk assessments. Stakeholder involvement is crucial for future applications to ensure effective risk management. Prepare for the end of coverage in 2024 by starting the application process early. Join the REACH Authorisation Alliance for strategic guidance and decision-making support.
The European Commission has authorized six uses of three substances: sodium dichromate, chromium trioxide, and sodium chromate, with review periods expiring on September 21, 2024. These authorizations involve companies like ZF Luftfahrttechnik GmbH and Wesco Aircraft EMEA Limited.
The European Commission's new regulation extends the validity of pre-registrations for REACH phase-in substances until December 31, 2019. Starting in 2020, pre-registrations will expire, requiring companies to undergo an inquiry for registration, with updated tonnage band calculations.